Cases of hepatocellular carcinoma (HCC), one of the most frequently occurring cancers throughout the world, are expected to increase dramatically in the next 10-15 years in Germany alone. The main reason is the increased occurrence of fatty hepatitis. Thus, in the future, interventional radiologists will also be increasingly involved in HCC patients treatment.
Am 2. November wurde das Heidelberger Ionenstrahl-Therapiezentrum (HIT) feierlich eröffnet. Die am GSI Helmholtzzentrum für Schwerionenforschung in Darmstadt entwickelte Krebstherapie steht nun erstmals im Routinebetrieb einer großen Patientenzahl zur Verfügung. Bislang wurden Patienten ausschließlich am Therapieplatz bei GSI behandelt. Die Therapie mit Ionenstrahlen…
Hologic is using the annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) at McCormick Place in Chicago, November 1 through 5, 2009, to feature the MammoSite ML radiation therapy system.
Founded and managed by Prof Peter Schlag, the Charité Comprehensive Cancer Centre (CCCC) co-ordinates cancer diagnostics and therapies across all medical disciplines. Interdisciplinary tumour boards decide on therapies/strategies; cooperation is close with general practitioners, regional hospitals and clinics.
Several health insurers now flag patients who have either exceeded a radiation dose threshold or have had over five CT examinations to the most vulnerable body areas.
Intra-operative radiotherapy (IORT) using the Intrabeam system from Carl Zeiss has been confirmed as a new alternative to the current approach to radiotherapy for breast cancer, by scientists and physicians at a symposium on IORT technological developments held in Germany.
Not long after the first earth was moved on a site in Wiener Neustadt (Vienna's Newtown), in the County of Lower Austria, and tests were carried out to ensure the long-term stability of a particle accelerator and weighty equipment in treatment and research facilities, we spoke with Professor Ramona Mayer, Medical Director at EBG MedAustron GmbH, about the firm's planning and future operation of…
Studies show promise for fast, 5-day therapy for early-stage breast cancer patients
IMRT is an evolving method of treatment for complex forms of cancer. Although patients benefit from treatment, a precise evaluation of that benefit and overall cost-effectiveness of the method is still an uncertain science. Mark Nicholls reports
To date, there is insufficient knowledge as to the cause of this disease, or how to prevent it. We asked some of our EH correspondents to report on measures taken in their countries to ensure that men are made more aware of this disease and whether screening services are provided for early prostate cancer detection.
Biomarkers are biochemical features or facets that can be used to measure the progress of disease or the effects of treatment.
The Institute of Cancer Research in London, UK, offers a new research tool for calculating emission spectra from X-ray systems on their website. The SpekCalc computer programm is made available free of charge to medical physicists who need to describe the spectrum generated by an X-ray set used in radiotherapy and diagnostic radiology.
Radiation can't be seen or felt; it has no smell and our senses can't feel it — still it can cause great harm. Therefore, many fears are associated with radiation.
It was a mistery: Why didn't drugs which boost the tumor-killing power of immune cells in lab do well in clincal trials? Now researchers from Rockefeller University describe a way to enhance the ability of these drugs by combining them with radiation therapy.
Proton therapy is very sophisticated way of destroying tumours. Now the Swedish Medical company RaySearch Laboratories has signed a consulting agreement with Uppsala University Hospital in Sweden to develop a treatment-planning system.
Limited public and political awareness of colorectal cancer (CRC), few formal screenings programms, delayed access to treatment - the first cross-country report on the management and funding of colorectal cancer (CRC) reveals an urgent need for action to improve the survival of patients in Europe and Australia.
When tumours are situated in difficult locations, e.g. near the brain, lungs, prostate or abdomen, patients treated with conventional radiation equipment often suffer severe side effects, which include bleeding, chronic infections or organ function limitations.
Along with paediatric radiology, interventional radiology will have a high profile at the 89th German Radiology Congress and 5th Joint Congress with the Austrian Radiology Society. During a discussion with Meike Lerner of European Hospital congress president Professor Dierk Vorwerk outlined what's on the agenda for the expected 6,900 visitors.
Artiste is a linear accelerator and CT scanner combined. At the German Cancer Research Centre, a team of scientists led by Professors Wolfgang Schlegel and Uwe Oelfke of the Medical Physics in Radiation Oncology division, contributed substantially to the technical development of the Artiste platform. They report that users will be able to observe and correct the actual position, extension and…
Prostate cancer is the most frequent cancer in men with about 49,000 newly diagnosed cancers in Germany and 6,000 in the Netherlands, annually.
Radiological services and equipment are not yet adapted to obese patients. The accuracy of current MRI, CT and Ultrasound is hindered by subcutaneous and intraabdominal fat. These modalities are crucial in diagnosing pathologies associated with obesity, including heart-related disease. Optimising imaging modalities will be a major challenge for radiology.
By Rudolf Schwarz and Andreas Krüll, of the Section of Radiation Oncology Department, Ambulanzzentrum GmbH of the University Medical Center Hamburg-Eppendorf
For individualised radiotherapy, high-precision delineation and characterisation of the tumour is critical. If highest radiation doses are delivered in a targeted fashion, the chance of tumour cell kill increases and tumour control probability is enhanced.
By Professor Robert D Speller, Head of the Radiation Physics Group, University College London, and Dr Alessandro Olivo, of the Medical Physics & Bioengineering Dept. University College London
According to a study published by Cancer Research UK scientists the survival rates of bladder cancer patients treated with radiotherapy are the same as those of patients undergoing radical cystectomy. The researchers investigated the medical records of 169 patients with invasive bladder cancer that were treated in Leeds between 1996 and 2000.
